| Sandoz Pharmaceuticals AG - Levetiracetam Sandoz 250 mg, Filmtabletten | | 62088 | | 01 | | Levetiracetam Sandoz 250 mg | | Filmtabletten | | N03AX14 | | Levetiracetam | | 14.10.2011 | | |
| | Composition | | levetiracetamum 250 mg, povidonum K 25, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.58 mg, crospovidonum, silica colloidalis anhydrica, talcum, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, macrogolum 6000, E 171, E 132, talcum, pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Levetiracetame | 250 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Levetiracetame | 250 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 132 | | color. | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Macrogol | 6000 | | | Magnesii Stearas | | | | Povidonum K | 25 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 Comprimé(s) | 8.41 | 25.55 | B | LS | Oui |
|
|
